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Sudden infant death syndrome (SIDS) continues to be a major public health issue.
Following its major decline since the “Back to Sleep” campaign, the incidence of SIDS
has plateaued, with an annual incidence of about 1,500 SIDS-related deaths in the United
States and thousands more throughout the world. The etiology of SIDS, the major cause
of postneonatal mortality in the western world, is still poorly understood. Although sleeping in prone position is a major risk factor, SIDS continues to occur even in the supine
sleeping position. The triple-risk model of Filiano and Kinney emphasizes the interaction
between a susceptible infant during a critical developmental period and stressor/s in the
pathogenesis of SIDS. Recent evidence ranges from dysregulated autonomic control
to findings of altered neurochemistry, especially the serotonergic system that plays an
important role in brainstem cardiorespiratory/thermoregulatory centers. Brainstem serotonin (5-HT) and tryptophan hydroxylase-2 (TPH-2) levels have been shown to be lower
in SIDS, supporting the evidence that defects in the medullary serotonergic system play
a significant role in SIDS. Pathogenic bacteria and their enterotoxins have been associated with SIDS, although no direct evidence has been established. We present a new
hypothesis that the infant’s gut microbiome, and/or its metabolites, by its direct effects
on the gut enterochromaffin cells, stimulates the afferent gut vagal endings by releasing
serotonin (paracrine effect), optimizing autoresuscitation by modulating brainstem 5-HT
levels through the microbiome–gut–brain axis, thus playing a significant role in SIDS
during the critical period of gut flora development and vulnerability to SIDS. The shared
similarities between various risk factors for SIDS and their relationship with the infant
gut microbiome support our hypothesis. Comprehensive gut-microbiome studies are
required to test our hypothesis.
Keywords: 5-HT, SIDS, gut–brain axis, gut flora, autoresuscitation
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INTRODUCTION

related to serotonergic autonomic system may play a role
in SIDS (24). In a recent study in neonatal rodents, loss of
brain stem 5HT may explain the cardiovascular collapse
during apparent severe hypoxic event in some SIDS cases
(25). Recent neuropathology studies in SIDS implicate
defective neurotransmitter function in the medullary arcuate nucleus, receptor immaturity of the “respiratory center”
nucleus tractus solitarius (NTS), and defective function of
the serotonergic raphé nuclei of the ponto-medullary ventral
median septum and other brainstem serotonergic neurons
(26). Abnormalities of the dorsal motor nucleus of the vagus
(DMNV) have been associated with SIDS (27). In a significant number of SIDS infants, cerebellar dentate nucleus
lesions may represent a developmental susceptibility leading
to autonomic cardiorespiratory/arousal dysfunction and
sleep-related death when exposed to homeostatic stressors
(28). Cummings et al. report that, in addition to respiratory
and cardiac dysfunction in normoxemic conditions, neonatal mice with reduced (by 60–70%) brainstem serotonergic
neurons from early embryogenesis onward (Pet-1−/−) have
major defects in autoresuscitation, a life-preserving process
utilized by neonatal mammals in severely hypoxic conditions
(29–33).
(4) Neurotransmitters: neurotransmitter systems (e.g., cholinergic and GABA-ergic) have been shown to be involved in
SIDS (34, 35). Reduced muscarinic cholinergic binding in
the medullary arcuate nucleus (involved in cardiorespiratory control) has been shown to occur in SIDS (34). GABA
neurons in the medulla help regulate homeostasis through
interactions with the medullary serotonergic system (35).
Significant decrease in GABA A receptor binding was found
in the medullary serotonergic system in SIDS cases associated with 5-HT defects (35).

Sudden infant death syndrome (SIDS) is defined as a sudden
unexplained death in the first year of life in a previously healthy
infant, where the cause of death remains unidentified despite
thorough investigations including a complete autopsy, death
scene investigation, and review of clinical history (1). SIDS is a
major cause of postneonatal infant mortality in the western world.
In the United States, ~1,500 infants died of SIDS in 2013 alone,
despite the steady reduction (1994–2000) in such deaths since the
“Back to Sleep” campaign. The incidence of SIDS has remained
fairly constant in the last decade, while the rate of other causes
of ill-defined, unspecified, and sudden unexpected infant deaths
has increased (1, 2). Some infant deaths, which would have been
classified as SIDS in the past, are now being classified as resulting
from suffocation and asphyxia. The significant reduction in SIDS
rate in the past 20 years may be related to increasing diagnoses of
other causes of death (1). Japan and the Netherlands have the lowest SIDS rates, at 0.09 and 0.1 per 1,000 live births, respectively,
whereas New Zealand has the highest reported SIDS rate (0.8 per
1,000 live births) (3–6). The United States and UK have SIDS rates
of 0.57 and 0.41 per 1,000 live births, respectively (7, 8). Prone
sleeping position, a significant SIDS risk factor, cannot be easily
associated with the other epidemiological risk factors related to
SIDS (9).

Current Hypotheses for SIDS

Sudden infant death syndrome is a condition without a widely
accepted singular pathological mechanism.
(1) Triple-risk model: this model proposes that SIDS occurs when
external stressors simultaneously act upon on a susceptible
infant with a vulnerable homeostatic system during a critical
developmental period (10).
(2) Failed autoresuscitation: animal studies have shown that cardiorespiratory, sleep, and arousal mechanisms are abnormal
following exposure to risk factors associated with SIDS or in
infants who later succumb to SIDS (11, 12). Although the
exact cause of SIDS is unknown, immaturity of brain stem
autonomic cardiorespiratory/thermoregulatory control
and failure of autoresuscitation during sleep are significant
determinants of survival (11, 12). A leading SIDS hypothesis
states that a structural/neurochemical brainstem abnormality results in failure of autoresuscitation following exposure
to a stressor during a critical developmental period (13, 14).
SIDS vulnerability is specific to failed autoresuscitation from
an adverse autonomic event (AAE). The initial self-initiated
gasp during such an event is dependent of optimal serotonin
homeostasis in the brain, which is undermined in SIDS.
Imbalance in serotonin homeostasis alters sleep rhythm, thus
increasing the chances of AAE (15).
(3) Medullary serotonergic network deficiency: SIDS is associated with multiple serotonergic defects including serotonin
deficiency (16–19). It has been associated with reduced
serotonin in the ventral medulla, pointing to a brainstembased autonomic dysfunction affecting sleep/arousal/
cardiorespiratory reflexes (20–23). Gene polymorphisms
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NEW HYPOTHESIS
We propose a new hypothesis that the infant gut microbiome
plays an important role in SIDS during the period critical to both
gut flora maturation/development and vulnerability to SIDS, by
modulating brainstem serotonergic system through the bidirectional microbiome–gut–brain axis, thus tilting the balance
in favor of successful autoresuscitation during a sleep-related
AAE. The components of our hypothesis, though individually
and separately studied in the past, have never been put together
as the structure of a SIDS hypothesis. The factors protective
against as well as the risk factors of SIDS show some compelling circumstantial evidence of their effects on gut microbiome
leading to beneficial and dysbiotic infant gut flora, respectively,
with corresponding effects on brainstem serotonergic system.
The plausibility of such an SIDS hypothesis would open up a
new paradigm for preventative and therapeutic approaches in
SIDS. Our hypothesis is the only one till date, which connects
the protective/risk factors of SIDS with infant gut flora, their
effect via microbiome–gut–brain axis on brainstem serotonergic system, and subsequent successful autoresuscitation
(Figure 1).
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Figure 1 | New sudden infant death syndrome hypothesis pathway: effect on infant gut flora on brainstem serotonin homeostasis and
autoresuscitation via microbiome–gut–brain axis.

Microbiome–Gut–Brain Axis

of the autonomic nervous system (49). The gut accounts for 95%
of the body’s serotonin content. The detailed structure, integration, and functioning of the various components of the above axis
have been reviewed extensively elsewhere (45).
Gut microbial colonization also plays a major role in the
postnatal development of the endocrine and immune systems,
which in turn support CNS function, particularly the developing serotonergic system (41, 42, 50–52). Neurotransmitters,
neurohormones, and receptors are ubiquitous in nature, e.g.,
catecholamines corticotrophin, somatostatin, and GABA derived
from bacteria (53–56). Evolutionally speaking, bacteria preceded
humans in developing neurotransmitters and recognizing them
(57–59). The ontogeny of neurochemicals in mammals has been
postulated to arise as a consequence of bacterial lateral gene
transfer (60). Thus, the gut microbiota might have played an
important role in the evolution of neurodevelopment (61).

The human adult gut has about 1014 microorganisms, 10-fold the
human cells and 150-fold the amount of human DNA (36, 37).
The human gut microbiome comprises more than 1,000 species,
predominantly obligate anaerobes, and includes viruses, protozoa, archaea, and fungi (36–39). Gastrointestinal homeostasis
has a significant role in the human general health and well-being
(39–41). The concept of the brain–gut axis involves the complex
bidirectional homeostatic neuronal communication through the
vagus nerve that exists between the central nervous system (CNS)
and the enteric nervous system (ENS) (42). Current research
studies the mechanism of such communication along this axis
and its relationship to normal homeostasis and disease states
(42–48). The basic skeleton of the microbiome–gut–brain axis
includes gut microbiome, the CNS, neuroendocrine and neuroimmune systems, ENS, sympathetic, and parasympathetic arms
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concentrations are dependent on peripheral content, which suggests that gut flora might play a part in regulating peripheral and
central serotonin synthesis (44, 80, 81). TPH2 is responsible for
the synthesis of serotonin in brainstem raphe nuclei, which is the
origin of most central serotonergic projections (82). Probiotics
have been shown to modulate serotonin—a critical central neurotransmitter through multiple strain-specific mechanisms (83).
Lyte et al. proposed a “delivery system” by which gut flora can
communicate neurochemical messages to the brain. Gut bacteria
produce and react to the same neurotransmitters (e.g., serotonin,
norepinephrine, dopamine, and GABA) that play a role centrally
in modulation of mood (84). Animal studies studying effects of
probiotics on CNS function have been extensively and systematically reviewed elsewhere (85). In addition, we have listed few
rodent studies looking at the role of pathogenic bacteria and vagus
on CNS neurochemistry and behavior (52, 86–92) (Table 1).

Gut Vagal Afferents and the Medullary Serotonergic
System

Sudden infant death syndrome is associated with multiple
serotonergic defects including serotonin deficiency and DMV
abnormalities (15–18, 62). We briefly review the vagal afferents,
brainstem respiratory neurons, and the medullary serotonergic
system.
Vagal afferents outnumber vagal efferents by 10:1, which are
sensitive to the paracrine effects of the enterochromaffin cells
(ECC), relay through nodose and dorsal root ganglia before
synapsing with second-order neurons in the spinal cord, which
in turn project into the brainstem. The brainstem has major
respiratory neurons concentrated into three recognizable groups
comprised of four major nuclei. These include the following: (1)
dorsal respiratory group (DRG) centered in the NTS; (2) ventral
respiratory group that encompasses the nucleus ambiguous and
the nucleus retroambigualis; (3) pre-Botzinger complex (preBotC) which contains putative pacemaker neurons; and (4) BotC
located in and near the nucleus retrofacialis. The DRG neurons
through the phrenic neurons in the cervical spinal cord control
the diaphragm.
The medullary serotonergic system projects to brainstem
cardiorespiratory nuclei (including the DMNV), cerebellum,
and spinal cord, thus modulating cardiorespiratory protective
reflexes, central chemoprotective reflexes, arousal/sleep cycles,
thermoregulatory reflexes, and maintenance of upper airway
patency (63).
Vagal afferents affect respiratory control as shown by altered
respiratory pattern after stimulation of visceral vagal afferents in
guinea pigs which died within a few hours of bilateral vagotomy;
their frequency of breathing significantly decreased within
minutes of the procedure (64, 65). Serotonin may regulate developmental brainstem neuronal apoptosis with its pro- or antiapoptotic effects as a result of the receptor sub-family activated (66).
Animal studies have shown that the highest density of 5-HT3
receptors are found within the afferent vagal fibers of dorsal
vagal complex (67, 68) and vagotomy was found to significantly
reduce receptor density (69–71). Stimulation of the NTS 5-HT3
receptors leads to elevation of blood pressure and inhibition of
the chemoreceptor-mediated bradycardia and the Bezold–Jarisch
reflexes. As an example of sensory neural plasticity, recent rat
studies have shown that glucose in the intestinal tract probably
induces serotonin release from neuroendocrine cells, which activates 5HT3 on vagal afferent terminals and transmitted centrally
(72–79).

Clinical Studies

Emerging evidence from clinical studies in autism indicates a
relationship between gut flora and cognitive function. Researchers
have reported gut flora dysbiosis with increases in Clostridium
spp. in autism (93). A probiotic mixture of Lactobacillus helveticus
and Bifidobacterium longum for a month has been reported to
decrease anxiety and depression in healthy human (94). Other
adult human clinical studies looking at probiotic effects on
neurobehavior have been systematically reviewed elsewhere (85).

Brain Affects Gut Microbiome

Stress induces gut permeability, which allows bacteria/bacterial antigen translocation across the epithelial barrier, thereby
activating immune response and resulting in changes in the gut
microbiome characteristics (95). Psychological stressors have
been reported to modulate infant gut microbiome (47). Prenatal
stressors have been reported to cause dysbiosis by decreasing gut
Bifidobacteria and Lactobacilli in infant rhesus monkeys (96).
In rodent studies, the stress of maternal separation significantly
decreased stool lactobacilli on the third day, which returned to
baseline by day 7 following separation (97). Stressors acting on
an at-risk infant during the critical window period could affect
the favorable nature of infant gut flora and consequently affect the
brainstem neurotransmitters through bidirectional communication and/or gut barrier function locally.
Based on the evidence from the experimental and clinical
studies discussed above, we propose that an optimal (diversity,
complexity, and colony counts) gut flora interacts with ECC and
modulates (possibly by its serotonin and other paracrine effects)
through the afferent vagal endings to the brain stem medullary
serotonergic cardiorespiratory centers in infants at risk for SIDS.
Recent research in microbiome–gut–brain axis supports role of
probiotics to modulate central brain neurochemistry, thus opening up a site for therapeutic targeting for central brain disorders.

Gut Microbiome Affects the Brainstem

There is emerging evidence from animal and clinical studies on
the role of gut microbiome in CNS signaling.

Animal Studies

Evidence from rodent studies indicates that the gut microbiome
can affect neural development, chemistry, and behaviors, e.g.,
emotion, pain perception, and stress responses. As rodent
gut colonization pattern is similar to humans, they are subjects of choice for gut microbiome studies. CNS tryptophan
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Shared Risk Factors for SIDS and Gut Dysbiosis

In the following section, we report how each of the protective as
well as risk factors for SIDS seems to offer evidence of promoting
symbiotic (favorable) and dysbiotic gut (non-favorable) flora,
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Table 1 | Animal studies showing effect of gut microbiome/probiotics on the central nervous system (CNS).
Reference

Study characteristics

1. Sudo et al.
(86)

Participants: mice study, in vivo. Germ-free (GF) at 9 weeks of age
Intervention: stress protocol
Controls: specific pathogen-free (SPF) BALBc mice, gnotobiotic mice
Primary outcome: plasma ACTH, corticosterone levels, fecal microflora analysis, plasma cytokine assays
Conclusion: plasma ACTH and corticosterone responses of GF mice were more susceptible to stress than those of SPF mice. Gut flora regulates the
development of the HPA stress response
2. Bravo et al. Participants: adult male BALB/c mice, in vivo (n = 36)
(87)
Intervention: Lactobacillus rhamnosus 109 cfu gavaged for 28 days
Control: control broth
Type of probiotic: L. rhamnosus (JB-1)
Primary outcome: corticosterone level, behavioral analysis, GABA B1b mRNA expression in hippocampus, amygdala, and locus coeruleus
Conclusion: L. rhamnosus supplementation reduced corticosterone response to stress and modulated the GABAergic system in mice. Vagotomized
mice did not show the neurochemical effects of this bacterium
3. Desbonnet Participants: adult Sprauge-Dawley rats (n = 20)
et al. (88)
Intervention: Bifidobacterium infantis 35624 gavaged for 14 days (n = 12)
Controls: n = 8
Type of probiotic: B. infantis 35624
Primary outcome: corticosterone level, tryptophan and IFN-g, TNF-alpha and IL-6, brain monoamines analysis
Conclusion: attenuation of pro-inflammatory immune responses and the elevation of the serotonergic precursor, tryptophan, in probiotic-treated group
4. Alenina
Participants: Tph2-deficient (Tph2−/−) mice, in vivo study
et al. (89)
Intervention: gene targeting leading to mice with absent TPH2, n = 4
Type of probiotic: none
Controls: n = 6
Primary outcome: serotonin in the brain of Tph2−/− mice
Conclusion: the lack of central serotonin in these mice leads to impaired early postnatal growth and altered autonomic control of sleep,
thermoregulation, and cardiorespiratory reflexes
5. Lyte et al.
Participants: 9-week-old CF-1 male mice, in vivo study
(84)
Intervention: in an animal model of IBD, infection with Citrobacter rodentium, to determine whether the infection could lead to anxiety-like behavior
Controls: saline
Type of probiotic: none
Primary outcome: tested for anxiety-like behavior measurement, immune cytokine analysis, and colon for histological analysis
Conclusion: C. rodentium infection could induce anxiety-like symptoms that are likely mediated via vagus
6. Gareau
Participants: mouse in vivo study
et al. (90)
Intervention: behavior was assessed following infection with the non-invasive enteric pathogen, C. rodentium in both C57BL/6 mice and GF SwissWebster mice
Primary outcome: whether daily treatment with probiotics normalized behavior was assessed
Conclusion: memory dysfunction occurred in infected mice exposed to acute stress, while in the GF setting, memory was altered at baseline
7. McVey
Participants: mouse ex vivo study
Neufeld et al. Intervention: segments of jejunum from 8- to 12-week old GF, SPF, and CONV-GF mice dissected to expose myenteric plexus. Intracellular recordings
(91)
by impaling cells with sharp microelectrodes
Type of probiotic: none
Primary outcome: action potential shapes, firing thresholds, the number of APs fired at 2× threshold, and passive membrane characteristics were
measured
Conclusion: commensal intestinal microbiota are essential for normal excitability of gut sensory neurons. When the vagus nerve is severed, effects of
gut bacteria on brain biochemistry, stress response, and behavior disappear
8. Heijtz et al. Participants: mouse in vivo study GF versus SPF mice with normal microbiological gut flora
(92)
Intervention: motor activity and anxiety-like behavior measured
Conclusion: unstressed GF mice were more active and willing to explore exposed areas of a maze than mice that had normal gut microbiota.
Transplanting normal gut bacteria into the GF mice erased those behavioral differences only in early life, suggesting that there is a critical window for
gut bacteria to establish normal patterns of behavior
9. Clarke
Participants: male GF animals compared with conventionally colonized control animals
et al. (52)
Intervention: measurement of 5-HT in hippocampus
Male GF animals have a sex-specific significant elevation in hippocampal 5-HT and 5-HIAA compared with conventionally colonized control animals.
Concentrations of tryptophan, the precursor of serotonin, are increased in the plasma of male GF animals, suggesting a humoral route through which
the microbiota can influence CNS serotonergic neurotransmission
Conclusion: microbiome–gut–brain axis in early life modulate hippocampal serotonin levels in a gender-dependent manner

respectively, during the critical window when both SIDS tends
to occur and early infant gut colonization is being established.

within the same countries (98). These differences may reflect
differences in maternal smoking, which could affect frequency and density of colonization of infants by potentially
pathogenic bacteria and induction/control of inflammatory
responses (98). Maternal cigarette smoking and/or alcohol
consumption may contribute to abnormal fetal medullary

Demographic Factors

(1) Ethnicity: studies in indigenous populations have reported
a higher SIDS rate compared to the non-indigenous groups
Frontiers in Pediatrics | www.frontiersin.org
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5-HT development in Native American SIDS infants (99). A
recent study has reported diet-related differences in gut flora
composition between African-Americans and native Africans.
African-Americans had higher levels of 7-α-dehydroxylating
bacteria and lower levels of Lactobacillus plantarum (which
produce methane and is protective against dysbiosis) (100,
101).
(2) Low socioeconomic status: SIDS has been associated with
lower socioeconomic groups (102). Fecal lactobacilli numbers have been related to socioeconomic status (103). Gut
flora differences related to diet, smoking status, and access
to health services could be a proxy for lower socioeconomic
status.
(3) Gender: SIDS shows a male preponderance. Animal studies
have shown gender differences in the regulation of serotonergic system (104, 105). Estrogen has been implicated in the
modulation of hippocampal serotoninergic system (106,
107). Gender influences gut microbiome (108–111) through
unclear mechanisms (110) including hormone–microbe
interactions (111, 112) and gender-specific immune
responses (113).
(4) Genetic control: genes regulating serotonergic network, brain
function and development, and cardiac function play an
important role in SIDS (114). Studying the role of genetics
on gut microbiome is important in understanding the pathogenesis of bacterial diseases (115, 116).

gut flora from their exposure to the immediate environment
(132). Aseptic precautions in obstetrics and neonatal units
may result in dysbiosis of the infant gut microbiome (133).

Postnatal Risks
(1)

(2)

(3)

Prenatal Risk Factors

(1) Maternal smoking: SIDS is five times more common in
infants born to mothers who smoked during pregnancy and
three times more common in those exposed postnatally to
smoking (117, 118). Cigarette smoke exposure and prone
sleep position is associated with decreased 5HT1A receptors in the DMNV of SIDS infants (119). A reduction in
5HT1A receptors has been reported in the DMNV of piglets
subjected to intermittent hypercapnic hypoxia and nicotine
exposure (120). A recent study showed that cessation of
smoking improved gut microbial diversity (121). Smoking
may play a role in SIDS through its effects on infant gut flora
and brainstem serotonin homeostasis.
(2) Being overweight: overweight infants and mothers have a
higher risk of SIDS (122). Obese human adults had less
Bacteroides and more Firmicutes in their gut flora compared with lean controls (123). A recent review looked at
maternal obesity-related pro-inflammatory state and its
effect on maternal and in utero fetal gut microbiome and
development (124).
(3) Delivery route: infants delivered by cesarean section have an
increased risk of SIDS than those born by vaginal route (125).
The mode of delivery has a significant effect on newborn gut
flora development (126–128). The gut flora in infants born by
cesarean may be altered till 6 months following delivery (129).
Prolonged duration of labor during vaginal birth increases
the chances of isolation of viable microbes from the stomach
and mouth of the infant (130, 131). In addition to exposure
to maternal flora, infants born by cesarean section acquire
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(4)

(5)
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Season: SIDS is more common during winter months
(134). There is an association of a viral infection in the
days preceding SIDS (135). Stressors such as viral infections during winter may cause dysbiosis in infants (136).
Such dysbiosis could play a role in successful autoresuscitation via microbiome–gut–brainstem pathway.
Low birth weight: the rate of SIDS is higher in low birth
weight infants (137). This may be related to the gut colonization patterns of very low birth weight (VLBW) infants
compared with normal weight infants. In an elegant study,
the initial gut colonization by Enterobacteria and Streptococci was similar in both VLBW and full-term infants;
however, both microorganisms predominated for a longer
period of time and the establishment of Bifidobacterium,
Bacteroides, Clostridium, and Lactobacillus was delayed in
VLBW infants (138).
Prone sleep position: prone sleeping position has been the
most important risk factor associated with SIDS (139). In
addition to decreased arousal response related to prone
sleeping, body temperature seems to be slightly elevated
in prone infants (140, 141). Prone sleep position has been
associated with Staphylococcus aureus gut colonization in
SIDS. The increased risk of ingestion/inhalation of bacteria contaminating the sleeping surface during prone position, with resultant gut dysbiosis, could account for the
increased risk of SIDS in such infants (22).
Breastfeeding: breastfeeding has been shown to be protective against SIDS (142, 143). Breast milk oligosaccharides
when fermented by gut flora to form fatty acids results in
modulation of infant gut flora. Breast-fed infants show
predominant proliferation of Bifidobacteria and Lactobacilli, whereas formula-fed infants show more Enterococci and Enterobacteria in their gut flora. In addition,
infants who are breast-fed exclusively have been reported to have better sleep arousal patterns than formula-fed
infants (144).
Elevated or reduced room temperature: overheating of
infants has been reported with an elevated risk of SIDS
(2, 145). Animal studies have showed that the presence
of certain gut flora elevates body temperature of mice
and rats. Conn et al. demonstrated that Gram-positive
organisms are a major source of the stimulatory effect
of gut flora on normal body temperature in mice (146).
Body temperature has been shown to have effects on the
intestinal flora of hibernating squirrels (147, 148). Oral
antibiotics have been shown to reduce nighttime body
temperature in rabbits as a result of their effect on their
native intestinal flora (149). These studies may help in understanding whether the increased body temperature as a
risk factor for SIDS could be a result of aberrant gut flora
or vice versa. Elevated body temperature associated with
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prone sleep position may also play a role in affecting gut
flora composition (140, 141).
(6) Pacifier use: pacifier sucking has been shown to be strongly
associated with the oral colonization of salivary lactobacilli (150). Thus, pacifier use might play a role in favorable
oral and subsequently gut flora in infants.
(7) Sleep surface, bedding, and stuffed toys: apart from mechanical suffocation and overheating issues, these may act as
fomites contributing to the infant gut flora. Sherburn et al.
showed that simulated infant head movements and mattress-related factors affect aerial release of bacteria from
beds (151).
(8) Co-sleeping: recent meta-analyses showed that bed sharing
during sleep increases the risk of SIDS, which is further
increased when combined with parental smoking, maternal alcohol consumption, and/or drug use (152). The
results of a Swedish study suggest that parental skin
S. aureus establish readily in the infant’s gut, perhaps due
to poor competition from other gut bacteria (153). The
possible role of acquiring abnormal gut flora from parents/
caregivers skin/gut flora by prolonged close contact during
bed sharing needs to be investigated further.
(9) Infant’s age: SIDS incidence peaks around 2–4 months
of the infant’s age, and subsequently decreases by 1 year.
Infant gut flora develops through a period of instability
in the early months of infancy and reaches more mature
adult-like microbiome by 1 year of age, the time by which
SIDS disappears. Another condition, not fully explained,
affecting the infant during a typical window period is infant colic, in which aberrant gut flora has been recently
shown to play a role, amenable to probiotics. Infantile colic is associated with a greater extent with near-miss SIDS
infants than among control infants, thereby hypothesizing
that colic might play a role as a protective arousal mechanism in such infants (154). From infection/immunity standpoint, this is the time when maternal antibodies
reach their nadir making infants more susceptible to infections, including from indigenous pathogenic gut flora.
Introduction of supplementary foods around 6 months of
age leads to more gut microbial diversity.
(10) Gestation at birth: prematurity is associated with a fourfold
increased risk of SIDS (137) as well as a dysbiotic intestinal flora, and impaired gut mucosal barrier function and
permeability (155–161). Lactobacillus GG has been shown

to decrease the frequency of Escherichia coli K1A translocation in a neonatal rabbit model (162, 163). Extremely
preterm newborns (<28 weeks) have a 5- to 10-fold higher
incidence of microbial infections than term newborn
(164). The preterm neonatal gut colonization is different
from that in the healthy, full-term infant gut. Preterm neonates requiring intensive care are colonized by organisms
such as Bifidobacteria only gradually and in a delayed
fashion. Schwiertz et al. reported similar bacterial colonization patterns in preterm infants in contrast to breast-fed,
full-term infants. Bacterial colonization has been observed
to be similar in different preterm neonates irrespective of
birth weight, feeding regime, and antibiotic therapy. The
initial colonization of the newborn GI tract is highly dependent on the environment, and cross-transmission of
bacteria is a serious problem in the hospital (165).
(11) Small for gestational age (SGA): it has been hypothesized
that SGA infants may have a higher incidence of SIDS as
a result of fetal hypoxia-induced decrease in brain serotonergic receptors (16, 166–169).

CONCLUSION
We have provided a new SIDS hypothesis whereby the right composition of gut flora in the early critical stage of infant development
could possibly optimize or modulate serotonin homeostasis in
the serotonergic cardiorespiratory/thermoregulatory brain stem
nuclei by a direct communication via the vagal afferents as part of
the microbiome–gut–brain axis. This may tip the balance in favor
of a successful autoresuscitation response to an AAE during sleep.
Investigating the role of infant microbiome using newer cultureindependent techniques as well as the developmental physiology
and neuropathology associated with SIDS may provide more
specific strategies than those available currently to define the at
risk population. As Hippocrates once stated “All diseases begin
in the gut,” research on the gut flora in at risk infants would open
new avenues for identifying potential biomarkers and strategies
for prevention (e.g., maternal and/or early postnatal probiotic/
synbiotic supplementation, diet changes) of SIDS (170).
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